{"id":"W4318672091","doi":"10.1002/cncr.34662","title":"A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Nausea; Internal medicine; PARP inhibitor; Toxicity; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Gastroenterology; Phases of clinical research; Surgery; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002019174,0.0006298213,0.00102396,0.0002728998,0.0003806414,0.0003442015,0.0005478546,0.0003995916,0.001428814],"category_scores_gemma":[0.001073325,0.0003304204,0.0006538274,0.0004406539,0.0005182857,0.0003165332,0.000360343,0.001421624,0.0002801063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001001938,"about_ca_system_score_gemma":0.00153793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002518346,"about_ca_topic_score_gemma":0.004271973,"domain_scores_codex":[0.9993895,0.0003978226,0.00002830485,0.00005994291,0.0000761131,0.00004820611],"domain_scores_gemma":[0.9994123,0.00009735459,0.0001493984,0.00004605394,0.0001000774,0.0001947834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3421919,0.1019245,0.0539946,0.002658634,0.002311659,0.001038697,0.0036686,0.008522415,0.1400654,0.000522354,0.006961197,0.33614],"study_design_scores_gemma":[0.2422089,0.5573471,0.1720651,0.00008357686,0.001065936,0.001259974,0.000296087,0.00555876,0.009813634,0.0003527833,0.009869804,0.00007837426],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996446,0.0005893831,0.0005198761,0.000224648,0.00001910563,0.00108527,0.0001140798,0.00002547224,0.0009761608],"genre_scores_gemma":[0.9941739,0.0009049673,0.002047035,0.0005233337,0.0000367852,0.001017121,0.0003354709,0.000008375196,0.0009529393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002518346,"threshold_uncertainty_score":0.01067859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02478210772695709,"score_gpt":0.3547496842867705,"score_spread":0.3299675765598134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}